Affiliations
AffiliationsItem in Clipboard
Trends in lung cancer screening in the United States, 2016-2017Ikenna C Okereke et al. J Thorac Dis. 2019 Mar.
. 2019 Mar;11(3):873-881. doi: 10.21037/jtd.2019.01.105. AffiliationsItem in Clipboard
AbstractBackground: Lung cancer is the most common cancer killer annually, yet the overall rate of eligible patients who undergo screening with low-dose computed tomography (LDCT) is low. Our goal was to determine factors which were associated with the probability of obtaining lung cancer screening.
Methods: The Clinformatics Data Mart (CDM) database, a national commercial health insurance database with over 18,000,000 enrollees, was queried to determine the rate of LDCT screening and factors which influenced receiving LDCT screening. All enrollees between the ages of 55 and 77 from 2016 to 2017 were included. Demographics, history of tobacco exposure and state smoking statistics were recorded.
Results: All 8,350,197 enrollees aged 55-77 were included in the study. Among enrollees, the rate of screening increased throughout 2016 and early 2017 and then appeared to stabilize. In the second half of 2017 the LDCT rate was approximately 6 per 1,000 enrollees per year, and was increasing at a slope of 0.1 additional LDCT per 1,000 enrollees per year. There was marked geographic variation, with 5-fold differences in LDCT rates between different regions. There was no correlation between smoking rate and LDCT rate at the state level (r=0.02; P=0.87). Enrollees aged 65-69 were most likely to be screened (OR =1.53; 1.45-1.61) compared to enrollees aged 55-59.
Conclusions: The rate of LDCT screening is increasing very slowly with time, and most eligible patients are not screened. Further studies are needed to determine the reasons for low screening rates, and the marked geographic variation.
Keywords: Early detection of cancer; lung neoplasms; tobacco smoking.
Conflict of interest statementConflicts of Interest: The authors have no conflicts of interest to declare.
FiguresFigure 1
Number of enrollees aged 55–77…
Figure 1
Number of enrollees aged 55–77 receiving LDCT screening, per 1,000 enrollees, per month,…
Figure 1Number of enrollees aged 55–77 receiving LDCT screening, per 1,000 enrollees, per month, in 2016 and 2017. The arrows indicate a significant (P<0.01) change in slope of the increase in LDCT rate. After May 2017, the rate of increase was close to 0, at 0.1 additional enrollee with LDCT per 1000 enrollees per year. LDCT, low-dose computed tomography.
Figure 2
Map showing percentage of enrollees…
Figure 2
Map showing percentage of enrollees aged 55–77 who underwent LDCT scan screening in…
Figure 2Map showing percentage of enrollees aged 55–77 who underwent LDCT scan screening in 2017, by state. States are color-coded by quintile of LDCT rate. LDCT, low-dose computed tomography.
Figure 3
Scatter plot for number of…
Figure 3
Scatter plot for number of enrollees aged 55–77, per thousand, undergoing LDCT screening…
Figure 3Scatter plot for number of enrollees aged 55–77, per thousand, undergoing LDCT screening in 2017 vs. number of current daily smokers per 1,000 among residents aged 55–79 in 2016. BRFSS data were used to estimate daily smoking rate. The correlation between the LDCT and smoking rates was r=0.02, P=0.87. LDCT, low-dose computed tomography.
Figure S1
Cohort selection using Clinformatics TM…
Figure S1
Cohort selection using Clinformatics TM Data Mart in 2016 and 2017.
Figure S1Cohort selection using ClinformaticsTM Data Mart in 2016 and 2017.
Similar articlesNishi SPE, Zhou J, Okereke I, Kuo YF, Goodwin J. Nishi SPE, et al. Chest. 2020 Feb;157(2):427-434. doi: 10.1016/j.chest.2019.08.2187. Epub 2019 Sep 12. Chest. 2020. PMID: 31521671 Free PMC article.
Nishi S, Zhou J, Kuo YF, Goodwin JS. Nishi S, et al. Mayo Clin Proc Innov Qual Outcomes. 2019 Feb 26;3(1):70-77. doi: 10.1016/j.mayocpiqo.2018.12.003. eCollection 2019 Mar. Mayo Clin Proc Innov Qual Outcomes. 2019. PMID: 30899910 Free PMC article.
Lewis JA, Samuels LR, Denton J, Edwards GC, Matheny ME, Maiga A, Slatore CG, Grogan E, Kim J, Sherrier RH, Dittus RS, Massion PP, Keohane L, Nikpay S, Roumie CL. Lewis JA, et al. JNCI Cancer Spectr. 2020 Jun 13;4(5):pkaa053. doi: 10.1093/jncics/pkaa053. eCollection 2020 Oct. JNCI Cancer Spectr. 2020. PMID: 33490864 Free PMC article.
Slatore CG, Baumann C, Pappas M, Humphrey LL. Slatore CG, et al. Ann Am Thorac Soc. 2014 May;11(4):619-27. doi: 10.1513/AnnalsATS.201312-460OC. Ann Am Thorac Soc. 2014. PMID: 24701999 Review.
Goulart BH, Bensink ME, Mummy DG, Ramsey SD. Goulart BH, et al. J Natl Compr Canc Netw. 2012 Feb;10(2):267-75. doi: 10.6004/jnccn.2012.0023. J Natl Compr Canc Netw. 2012. PMID: 22308519 Review.
Marcatti M, Saada J, Okereke I, Wade CE, Bossmann SH, Motamedi M, Szczesny B. Marcatti M, et al. Cells. 2021 Apr 6;10(4):819. doi: 10.3390/cells10040819. Cells. 2021. PMID: 33917426 Free PMC article.
Li CC, Matthews AK, Kao YH, Lin WT, Bahhur J, Dowling L. Li CC, et al. Front Public Health. 2021 Aug 25;9:684558. doi: 10.3389/fpubh.2021.684558. eCollection 2021. Front Public Health. 2021. PMID: 34513780 Free PMC article.
Alaniz-Cantú EI, Goodwin K, Smith L, Acosta E, Chávez-Iñiguez A, Evans MJ, Gaitán M, Lei F, Yousefi-Nooraie R, Fiscella KA, Rivera MP, Cupertino AP, Cartujano-Barrera F. Alaniz-Cantú EI, et al. Front Oncol. 2024 Mar 20;14:1365739. doi: 10.3389/fonc.2024.1365739. eCollection 2024. Front Oncol. 2024. PMID: 38571494 Free PMC article.
Doan C, Li S, Goodwin JS. Doan C, et al. JAMA Netw Open. 2023 Feb 1;6(2):e2255589. doi: 10.1001/jamanetworkopen.2022.55589. JAMA Netw Open. 2023. PMID: 36735262 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3